Protalix BioTherapeutics, Inc.
PLX · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,355 | $164 | -$3,619 | $6,494 |
| Dep. & Amort. | $372 | $360 | $346 | $334 |
| Deferred Tax | $59 | $231 | -$113 | $0 |
| Stock-Based Comp. | $598 | $427 | $540 | $654 |
| Change in WC | -$7,136 | -$6,899 | -$1,840 | -$3,447 |
| Other Non-Cash | $20 | $484 | -$372 | -$44 |
| Operating Cash Flow | -$3,732 | -$5,233 | -$5,058 | $3,991 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$498 | -$431 | -$306 | -$425 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$6 | -$7 | -$6 | -$14,895 |
| Investing Cash Flow | -$504 | -$438 | -$312 | -$15,320 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $3,951 | $2,861 | $3,626 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $153 | $2,215 | $0 |
| Financing Cash Flow | $0 | $4,104 | $5,076 | $3,626 |
| Forex Effect | -$12 | $4 | -$8 | $54 |
| Net Chg. in Cash | -$4,248 | -$1,563 | -$302 | -$7,649 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,895 | $19,458 | $19,760 | $27,409 |
| End Cash | $13,647 | $17,895 | $19,458 | $19,760 |
| Free Cash Flow | -$4,230 | -$5,664 | -$5,364 | $3,566 |